Login / Signup

Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage.

Soon Chang ParkSeok-Ran YeomSang Kyoon HanYoung Mo JoHyung Bin Kim
Published in: Korean journal of critical care medicine (2017)
This analysis aimed to support that the administration of rFVIIa can reduce the severity of life-threatening PPH in patients. A rapid decision regarding the administration of rFVIIa is needed for a more favorable outcome in severe PPH patients for whom there is no effective standard treatment.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • combination therapy
  • patient reported
  • data analysis